Science Explorer Back to mapMap
Discussion
Company · Osaka · ??

Mitsubishi Tanabe Pharma Corporation

In research, Mitsubishi Tanabe Pharma Corporation stands highest in Medicine (#4,140 of 14,558 worldwide), Health Sciences (#4,772 of 16,688 worldwide) and Life Sciences (#3,523 of 11,023 worldwide), over all time.

World rank, all time
#13,418
of 34,923
Rank in ??
#142
of 615
Research works
327
▼ 25% vs 2018-21
Citations
9.3k
28.3 per fractional work
Top-10% rate
7.7%
all institutions 10.0%
vs its own fields
0.94×
1.00× is exactly expected
Open access
60%
world 40%
International
12%
world 18%

What is Mitsubishi Tanabe Pharma Corporation known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #4,140 of 14,558 10.7%149
Health SciencesDomain #4,772 of 16,688 10.5%152
Life SciencesDomain #3,523 of 11,023 7.4%128

Each strip is that field's whole ranked pool, with the notch where Mitsubishi Tanabe Pharma Corporation sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Mitsubishi Tanabe Pharma Corporation work in?

In 2022-now, 53% of research at Mitsubishi Tanabe Pharma Corporation is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (6%). It does 2.3× the world's share of Life Sciences.

Health Sciences: 30 fractional works · 52.8% of its workMedicine: 29 fractional works · 50.6% of its workNeurology: 4 fractional works · 6.6% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 4.1% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 3.3% of its workPulmonary and Respiratory Medicine: 2 fractional works · 3.3% of its workRheumatology: 2 fractional works · 3.3% of its workPsychiatry and Mental health: 2 fractional works · 3.2% of its workEpidemiology: 2 fractional works · 3.0% of its workPathology and Forensic Medicine: 2 fractional works · 2.9% of its workPhysiology: 2 fractional works · 2.8% of its workHematology: 2 fractional works · 2.7% of its workHepatology: 1 fractional works · 2.3% of its workSurgery: 1 fractional works · 2.0% of its workGenetics: 1 fractional works · 1.6% of its workNephrology: 1 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.3% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.1% of its workOncology: 1 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.8% of its workImmunology and Allergy: 0 fractional works · 0.7% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.5% of its workUrology: 0 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 1 fractional works · 1.7% of its workNutrition and Dietetics: 1 fractional works · 1.7% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.3% of its workLife Sciences: 21 fractional works · 37.1% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 25.0% of its workMolecular Biology: 11 fractional works · 19.9% of its workCell Biology: 1 fractional works · 1.5% of its workGenetics: 1 fractional works · 1.5% of its workCancer Research: 0 fractional works · 0.8% of its workClinical Biochemistry: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.4% of its workImmunology and Microbiology: 4 fractional works · 6.2% of its workImmunology: 3 fractional works · 5.6% of its workMicrobiology: 0 fractional works · 0.6% of its workNeuroscience: 2 fractional works · 3.3% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.3% of its workNeurology: 0 fractional works · 0.8% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.6% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workDevelopmental Neuroscience: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.5% of its workPharmacology: 1 fractional works · 1.9% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 5 fractional works · 8.9% of its workChemistry: 2 fractional works · 3.4% of its workOrganic Chemistry: 1 fractional works · 2.5% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.4% of its workSpectroscopy: 0 fractional works · 0.4% of its workComputer Science: 2 fractional works · 3.3% of its workComputational Theory and Mathematics: 2 fractional works · 3.0% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workMaterials Science: 1 fractional works · 0.9% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workBiomaterials: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.6% of its workStatistics and Probability: 0 fractional works · 0.6% of its workEngineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 1.2% of its workSocial Sciences: 0 fractional works · 0.6% of its workUrban Studies: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workEconomics and Econometrics: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.2% of its workManagement Science and Operations Research: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workALL ITS WORKMitsubishi TanabePharma…56fractional works, 2022-now
Life Sciences37%Physical Sciences9%Health Sciences53%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine2950.6%
    2. Nursing11.7%
    3. Veterinary00.3%
    4. Health Professions00.3%
    1. Biochemistry, Genetics and Molecular Biology1425.0%
    2. Immunology and Microbiology46.2%
    3. Neuroscience23.3%
    4. Pharmacology, Toxicology and Pharmaceutics12.5%
    5. Agricultural and Biological Sciences00.1%
    1. Chemistry23.4%
    2. Computer Science23.3%
    3. Materials Science10.9%
    4. Mathematics00.6%
    5. Engineering00.4%
    6. Environmental Science00.1%
    7. Earth and Planetary Sciences00.1%
    1. Social Sciences00.6%
    2. Economics, Econometrics and Finance00.2%
    3. Decision Sciences00.2%
    4. Psychology00.1%
    5. Business, Management and Accounting00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.02× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.68× its world share, 14 worksBiochemistry, Geneti…Immunology and Microbiology: 6.18× its world share, 4 worksImmunology and Micro…Neuroscience: 2.01× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.10× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.16× its world share, 2 worksChemistryComputer Science: 0.43× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.08× its world share, 0 worksEarth and Planetary …Engineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.27× its world share, 0 worksMaterials ScienceMathematics: 0.48× its world share, 0 worksMathematicsHealth Professions: 0.10× its world share, 0 worksHealth ProfessionsMedicine: 2.63× its world share, 29 worksMedicineNursing: 3.41× its world share, 1 worksNursingVeterinary: 2.37× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.23× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.12× its world share, 0 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.1×. Every wedge is a field page.

All 21 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics7.10×1 works
  2. Immunology and Microbiology6.18×4 works
  3. Biochemistry, Genetics and Molecular Biology4.68×14 works
  4. Nursing3.41×1 works
  5. Medicine2.63×29 works
  6. Veterinary2.37×0 works
  7. Chemistry2.16×2 works
  8. Neuroscience2.01×2 works
  9. Mathematics0.48×0 works
  10. Computer Science0.43×2 works
  11. Materials Science0.27×0 works
  12. Decision Sciences0.23×0 works
  13. Economics, Econometrics and Finance0.12×0 works
  14. Health Professions0.10×0 works
  15. Earth and Planetary Sciences0.08×0 works
  16. Psychology0.05×0 works
  17. Social Sciences0.05×0 works
  18. Engineering0.03×0 works
  19. Environmental Science0.03×0 works
  20. Agricultural and Biological Sciences0.02×0 works
  21. Business, Management and Accounting0.02×0 works

Who are the top researchers at Mitsubishi Tanabe Pharma Corporation?

Ranked on the quality score, Kenji Chiba, Toru Yoshinari and Rikiya Ohashi lead among researchers whose main affiliation is Mitsubishi Tanabe Pharma Corporation.

  1. 1 Kenji Chiba #576,759 worldwide 6.3k citations · 128 works
  2. 2 Toru Yoshinari #749,533 worldwide 1.1k citations · 32 works
  3. 3 Rikiya Ohashi #775,008 worldwide 3.5k citations · 58 works
  4. 4 Satoshi Yuki #942,315 worldwide 2.3k citations · 38 works
  5. 5 Takuma Tsuchida #1,046,902 worldwide 4k citations · 16 works
  6. 6 Hirotoshi Kataoka #1,049,109 worldwide 2k citations · 32 works
  7. 7 Kenji Arakawa #1,167,243 worldwide 1.7k citations · 40 works
  8. 8 Kiichiro Ueta #1,213,973 worldwide 2.3k citations · 42 works
  9. 9 Tsuyoshi Suzuki #1,504,271 worldwide 1.9k citations · 55 works
  10. 10 Kunio Sugahara #1,553,176 worldwide 1.9k citations · 70 works
All ranked researchers at Mitsubishi Tanabe Pharma Corporation

What are the most cited papers from Mitsubishi Tanabe Pharma Corporation?

The most cited paper from Mitsubishi Tanabe Pharma Corporation is "Mechanisms of hepatic stellate cell activation" (Takuma Tsuchida, Scott L. Friedman, 2017), with 2,956 citations. Next come "A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer" (588) and "The influence of cytokines on the complex pathology of ulcerative colitis" (454).

Most cited papers
#PaperReleasedCitations
1 Mechanisms of hepatic stellate cell activation Takuma Tsuchida, Scott L. Friedman · Nature Reviews Gastroenterology & Hepatology Review 10 May 2017 2,956
2 A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer Takuma Tsuchida, Youngmin A. Lee, Naoto Fujiwara et al. · Journal of Hepatology Open access 20 Mar 2018 588
3 The influence of cytokines on the complex pathology of ulcerative colitis Hiroshi Nakase, Noriko Sato, Naomi Mizuno et al. · Autoimmunity Reviews Open access 10 Dec 2021 454
4 Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis Nobuhiro Nakamoto et al. · Nature Microbiology 3 Jan 2019 429
5 CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity Chao Wang et al. · Cell Open access 19 Nov 2015 409
All 61 most cited papers, with filters and sorting

Which keywords describe research at Mitsubishi Tanabe Pharma Corporation?

By fractional works in 2022-now, weighted toward what it does more of than the world: Genetics, Neurodegeneration, Inflammation, Autoantibodies, Cardiovascular Disease, Medicinal Chemistry, Pharmacokinetics and Treatment.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation4▲ 3.7×26 topics
  2. Genetics4▲ 9.8×8 topics
  3. Epidemiology4▲ 1.55×21 topics
  4. Neurodegeneration4▲ 20×6 topics
  5. Cardiovascular Disease3▲ 5.0×13 topics
  6. Oxidative Stress3▲ 3.5×12 topics
  7. Treatment3▲ 4.3×10 topics
  8. Autoantibodies3▲ 21×5 topics
  9. Medicinal Chemistry2▲ 16×4 topics
  10. Cancer2▲ 3.1×14 topics
  11. Pharmacokinetics2▲ 15×2 topics
  12. FUS/TLS2▲ 163×1 topic
  13. Metabolic Syndrome2▲ 4.7×7 topics
  14. TDP-432▲ 163×1 topic
  15. Mitochondrial Dysfunction2▲ 13×6 topics
  16. Diagnostic Criteria2▲ 15×3 topics
  17. Heart Failure2▲ 7.9×5 topics
  18. Cancer Treatment2▲ 14×4 topics
  19. Chronic Kidney Disease2▲ 14×6 topics
  20. Diabetes2▲ 5.9×8 topics
  21. Fibrosis2▲ 15×6 topics
  22. Molecular Docking2▲ 24×1 topic
  23. Neuroprotection2▲ 8.7×5 topics
  24. Virtual Screening2▲ 33×1 topic
  25. Liver Transplantation2▲ 23×3 topics
  26. Capacity Building2▲ 45×2 topics
  27. TGF-ß2▲ 17×4 topics
  28. Drug Discovery1▲ 11×6 topics
  29. Immunosuppressive Therapy1▲ 13×3 topics
  30. Endothelial Dysfunction1▲ 10×5 topics
  31. Hypertension1▲ 8.0×5 topics
  32. Stroke1▲ 14×3 topics
  33. Autoimmunity1▲ 14×3 topics
  34. Parkinson's Disease1▲ 8.6×6 topics
  35. TGF-ß Signaling1▲ 30×3 topics
  36. Anemia1▲ 20×2 topics
  37. Antisense Oligonucleotides1▲ 47×2 topics
  38. Drug Design1▲ 29×2 topics
  39. Iron Deficiency1▲ 38×2 topics
  40. Toll-like Receptors1▲ 18×2 topics

Which research topics does Mitsubishi Tanabe Pharma Corporation publish most on?

By volume in 2022-now: Amyotrophic Lateral Sclerosis Research, Computational Drug Discovery Methods, Biotechnology and Related Fields and Systemic Lupus Erythematosus Research.

  1. 1 Amyotrophic Lateral Sclerosis Research Neurology 2 works
  2. 2 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
  3. 3 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
  4. 4 Systemic Lupus Erythematosus Research Rheumatology 1 works
  5. 5 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
  6. 6 Erythropoietin and Anemia Treatment Hematology 1 works
  7. 7 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
  8. 8 T-cell and B-cell Immunology Immunology 1 works
  9. 9 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 1 works
  10. 10 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.7%not open40.3%

World: 40% of research is openly available.

with international co-authors12.5%domestic only87.5%

World: 18% is written across borders.

How has Mitsubishi Tanabe Pharma Corporation's research output changed?

Output in 2022-2025 was 25% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Mitsubishi Tanabe Pharma Corporation as a percentage of every work published that year, 0.00028% in 2024.

still counting0.00025%0.00050%0.00075%Mitsubishi Tanabe Pharma Corporation0.00012% in 202520102020

Fractional works of Mitsubishi Tanabe Pharma Corporation over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%all institutions10.0% in 2022Mitsubishi Tanabe Pharma Corporation3.4% in 20222020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.2% in 2019.

Other research institutions in Osaka

All research institutions in Osaka

Share Mitsubishi Tanabe Pharma Corporation's ranking

Mitsubishi Tanabe Pharma Corporation on Science Explorer

A card with Mitsubishi Tanabe Pharma Corporation's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Mitsubishi Tanabe Pharma Corporation. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.